Benchmarking is no longer just about comparison, it’s a strategic tool for uncovering performance gaps, identifying best practices, and making smarter, data-driven decisions. When done right, it transforms raw data into actionable insight, helping organizations sharpen their competitive position and drive measurable advantage.
The 2026 Competitive Marketing Summit highlighted how marketing is evolving in an AI-driven world. From competitive intelligence to balancing automation with creativity, this recap explores the key themes shaping the future of modern marketing.
Pharmaceutical workshops turn competitive intelligence into actionable strategy. By aligning cross-functional teams, they help organizations interpret market dynamics and prepare for critical moments across the drug lifecycle.
Mastering price realization means understanding where your revenue is lost between list price and pocket price. By identifying hidden leaks, from discounts to rebates and logistics costs, businesses can take control of pricing and protect profitability.
Pharmaceutical competitive intelligence transforms raw competitor, regulatory, and market data into forward-looking strategic insight that helps life sciences companies anticipate competitor moves, shape evidence and launch planning, and make decisions that drive differentiated performance across the drug development lifecycle.
Learn how strategic benchmarking transforms budget planning from guesswork into a data-driven process that aligns spending with market realities and competitive performance.
Benchmarking only delivers strategic value when it’s intentional and contextual, without clearly defined objectives, the right peer group, and an understanding of what metrics truly mean, organizations risk drawing misleading conclusions and wasting valuable time and resources. Done wrong, generic or one-off reports can skew decisions; done right, continuously updated and customized benchmarks become a powerful engine for informed decision-making and competitive advantage.
Competitive intelligence has become a strategic necessity in life sciences as pipelines grow more complex and competition accelerates. This article explores how CI teams are evolving to deliver earlier, more actionable insights that support high-stakes decision-making.
Continuous benchmarking replaces static, annual comparisons with ongoing performance tracking, helping organizations identify risks earlier and make more informed, timely strategic decisions.
Artificial intelligence is increasingly shaping life sciences competitive intelligence, but most organizations are still early in practical adoption. Sedulo Group’s research shows that while many CI teams see efficiency gains from AI, few have fully embedded it into standardized, decision-ready workflows.
